xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05990270</url>
    </required_header>
    <id_info>
      <org_study_id>KahramanmaraşSIUU</org_study_id>
      <nct_id>NCT05990270</nct_id>
    </id_info>
    <brief_title>The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief</brief_title>
    <acronym>EEWCCKAB</acronym>
    <official_title>The Effect of Education Given to Women on Knowledge, Attitudes and Beliefs on Cervical Cancer</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Kahramanmaras Sutcu Imam University</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>Kahramanmaras Sutcu Imam University</source>
    <oversight_info>
      <has_dmc>No</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        Aim: The aim of this study is to reveal the effect of education given to women about cervical&#xD;
        cancer on knowledge, attitude and belief.&#xD;
  &#xD;
        Material and Method: This randomized controlled study was conducted with 130 who had a public&#xD;
        hospital located in Southeast Turkey (51 experimental, 51 control).&#xD;
      </textblock>
    </brief_summary>
    <detailed_description>
      <textblock>
        Aim: The aim of this study is to reveal the effect of education given to women about cervical&#xD;
        cancer on knowledge, attitude and belief.&#xD;
  &#xD;
        Material and Method: This randomized controlled study was conducted with 130 who had a public&#xD;
        hospital located in Southeast Turkey (51 experimental, 51 control).&#xD;
  &#xD;
        In the first stage, the researcher participants were informed about the purpose of the&#xD;
        researcher and the questionnaire, and their consent was obtained for participation in the&#xD;
        study.&#xD;
  &#xD;
        In the second stage, pre-test data will be obtained with the face-to-face interview method of&#xD;
        the research data and a questionnaire form. Cervical cancer education will be provided. (The&#xD;
        training is in three sessions, each session will last 20-30 minutes. In the training;&#xD;
        Cervical cancer, ppt presentation on HPV virus, question-answer method, female pelvic anatomy&#xD;
        on the gynecological examination model, gynecological examination, how the Pap Test is done,&#xD;
        and cervical cancer pathologies. will be explained )) After the training, the post-test data&#xD;
        will be obtained by applying the questionnaire again.&#xD;
      </textblock>
    </detailed_description>
    <overall_status>Recruiting</overall_status>
    <start_date type="Anticipated">August 15, 2023</start_date>
    <completion_date type="Anticipated">December 30, 2023</completion_date>
    <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
    <phase>N/A</phase>
    <study_type>Interventional</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <allocation>Randomized</allocation>
      <intervention_model>Parallel Assignment</intervention_model>
      <intervention_model_description>Parallel Assignment</intervention_model_description>
      <primary_purpose>Supportive Care</primary_purpose>
      <masking>None (Open Label)</masking>
      <masking_description>None (Open Label)</masking_description>
    </study_design_info>
    <primary_outcome>
      <measure>First Measurement: Human Papilloma Virus (HPV) Knowledge Scale</measure>
      <time_frame>Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.</time_frame>
      <description>ASSESSMENT OF WOMEN'S AWARENESS ON HPV</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Second Measurement:Cervical Cancer and Pap-Smear Test Health Belief Model Scale</measure>
      <time_frame>Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.</time_frame>
      <description>ASSESSMENT OF HEALTH BELIEFS</description>
    </primary_outcome>
    <number_of_arms>2</number_of_arms>
    <enrollment type="Anticipated">102</enrollment>
    <condition>Cancer of Cervix</condition>
    <condition>HPV Infection</condition>
    <arm_group>
      <arm_group_label>EXPERIMENTAL GROUP</arm_group_label>
      <arm_group_type>Experimental</arm_group_type>
      <description>Cervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again.</description>
    </arm_group>
    <arm_group>
      <arm_group_label>control group</arm_group_label>
      <arm_group_type>No Intervention</arm_group_type>
    </arm_group>
    <intervention>
      <intervention_type>Behavioral</intervention_type>
      <intervention_name>education</intervention_name>
      <description>Cervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again.</description>
      <arm_group_label>EXPERIMENTAL GROUP</arm_group_label>
    </intervention>
    <eligibility>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  least literate, no communication problem women who agreed to participate in the study&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  literate are women who do not have communication problems (hearing impairment, visual&#xD;
               impairment)&#xD;
        </textblock>
      </criteria>
      <gender>Female</gender>
      <minimum_age>N/A</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
    </eligibility>
    <overall_official>
      <last_name>HATİCE GÜL ÖZTAŞ</last_name>
      <role>Study Director</role>
      <affiliation>KahramanmaraşISU</affiliation>
    </overall_official>
    <overall_contact>
      <last_name>HATİCE GÜL ÖZTAŞ</last_name>
      <phone>0542826762</phone>
      <email>haticeguloztas@ksu.edu.tr</email>
    </overall_contact>
    <overall_contact_backup>
      <last_name>KEVSER IŞIK</last_name>
      <phone>+90 553 724 82 97</phone>
      <email>kevser_isik@hotmail.com</email>
    </overall_contact_backup>
    <location>
      <facility>
        <name>Kahramanmaraş ISU</name>
        <address>
          <city>Kahramanmaraş</city>
          <state>K.Maraş</state>
          <zip>46100</zip>
          <country>Turkey</country>
        </address>
      </facility>
      <status>Recruiting</status>
      <contact>
        <last_name>Hatice Gül Öztaş, Phd</last_name>
        <phone>05428267629</phone>
        <email>haticeguloztas@ksu.edu.tr</email>
      </contact>
    </location>
    <location_countries>
      <country>Turkey</country>
    </location_countries>
    <verification_date>July 2023</verification_date>
    <study_first_submitted>July 28, 2023</study_first_submitted>
    <study_first_submitted_qc>August 5, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 14, 2023</study_first_posted>
    <last_update_submitted>August 5, 2023</last_update_submitted>
    <last_update_submitted_qc>August 5, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">August 14, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Principal Investigator</responsible_party_type>
      <investigator_affiliation>Kahramanmaras Sutcu Imam University</investigator_affiliation>
      <investigator_full_name>Hatice Gul OZTAS</investigator_full_name>
      <investigator_title>PhD, Assist. Prof. Dr</investigator_title>
    </responsible_party>
    <keyword>Cervical cancer,</keyword>
    <keyword>early diagnosis,</keyword>
    <keyword>Pap smear,</keyword>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Papillomavirus Infections</mesh_term>
      <mesh_term>Uterine Cervical Neoplasms</mesh_term>
    </condition_browse>
    <patient_data>
      <sharing_ipd>No</sharing_ipd>
    </patient_data>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05990270
  org study id: KahramanmaraşSIUU
  nct id: NCT05990270
  lead sponsor: 
  has dmc: No
  is fda regulated drug: No
  is fda regulated device: No
  Aim: The aim of this study is to reveal the effect of education given to women about cervical
        cancer on knowledge, attitude and belief.
  
        Material and Method: This randomized controlled study was conducted with 130 who had a public
        hospital located in Southeast Turkey (51 experimental, 51 control).
  Aim: The aim of this study is to reveal the effect of education given to women about cervical
        cancer on knowledge, attitude and belief.
  
        Material and Method: This randomized controlled study was conducted with 130 who had a public
        hospital located in Southeast Turkey (51 experimental, 51 control).
  
        In the first stage, the researcher participants were informed about the purpose of the
        researcher and the questionnaire, and their consent was obtained for participation in the
        study.
  
        In the second stage, pre-test data will be obtained with the face-to-face interview method of
        the research data and a questionnaire form. Cervical cancer education will be provided. (The
        training is in three sessions, each session will last 20-30 minutes. In the training;
        Cervical cancer, ppt presentation on HPV virus, question-answer method, female pelvic anatomy
        on the gynecological examination model, gynecological examination, how the Pap Test is done,
        and cervical cancer pathologies. will be explained )) After the training, the post-test data
        will be obtained by applying the questionnaire again.
  allocation: Randomized
  intervention model: Parallel Assignment
  intervention model description: Parallel Assignment
  primary purpose: Supportive Care
  masking: None (Open Label)
  masking description: None (Open Label)
  measure: First Measurement: Human Papilloma Virus (HPV) Knowledge Scale
  time frame: Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.
  description: ASSESSMENT OF WOMEN'S AWARENESS ON HPV
  measure: Second Measurement:Cervical Cancer and Pap-Smear Test Health Belief Model Scale
  time frame: Measurement at the second encounter (1 WEEK AFTER TRAINING) for each group.
  description: ASSESSMENT OF HEALTH BELIEFS
  arm group label: EXPERIMENTAL GROUP
  arm group type: Experimental
  description: Cervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again.
  arm group label: control group
  arm group type: No Intervention
  intervention type: Behavioral
  intervention name: education
  description: Cervical cancer education will be provided. (The training will be in three sessions, each session will last 20-30 minutes. In the training; ppt presentation for cervical cancer, HPV virus, question and answer method will be used. In addition, female pelvic anatomy, gynecological examination, how the Pap Test is done, and cervical exam on the gynecological examination model. will be explained by showing cancer pathologies ) After the training, the final test data will be obtained by applying the questionnaire again.
  arm group label: EXPERIMENTAL GROUP
  criteria: 
  gender: Female
  minimum age: N/A
  maximum age: N/A
  healthy volunteers: Accepts Healthy Volunteers
  last name: HATİCE GÜL ÖZTAŞ
  role: Study Director
  affiliation: KahramanmaraşISU
  last name: HATİCE GÜL ÖZTAŞ
  phone: 0542826762
  email: haticeguloztas@ksu.edu.tr
  last name: KEVSER IŞIK
  phone: +90 553 724 82 97
  email: kevser_isik@hotmail.com
  facility: 
  status: Recruiting
  contact: 
  country: Turkey
  responsible party type: Principal Investigator
  investigator affiliation: Kahramanmaras Sutcu Imam University
  investigator full name: Hatice Gul OZTAS
  investigator title: PhD, Assist. Prof. Dr
  mesh term: Papillomavirus Infections
  mesh term: Uterine Cervical Neoplasms
  sharing ipd: No